Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Inventory Average (2021 - 2025)

Historic Inventory Average for Treace Medical Concepts (TMCI) over the last 5 years, with Q3 2025 value amounting to $41.9 million.

  • Treace Medical Concepts' Inventory Average fell 125.93% to $41.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.9 million, marking a year-over-year decrease of 125.93%. This contributed to the annual value of $34.2 million for FY2024, which is 4101.9% up from last year.
  • Treace Medical Concepts' Inventory Average amounted to $41.9 million in Q3 2025, which was down 125.93% from $40.2 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Inventory Average ranged from a high of $42.4 million in Q3 2024 and a low of $7.5 million during Q2 2021
  • For the 5-year period, Treace Medical Concepts' Inventory Average averaged around $24.7 million, with its median value being $24.3 million (2023).
  • As far as peak fluctuations go, Treace Medical Concepts' Inventory Average skyrocketed by 10024.71% in 2023, and later crashed by 125.93% in 2025.
  • Over the past 5 years, Treace Medical Concepts' Inventory Average (Quarter) stood at $10.5 million in 2021, then skyrocketed by 72.74% to $18.1 million in 2022, then soared by 62.1% to $29.3 million in 2023, then soared by 41.51% to $41.4 million in 2024, then rose by 1.15% to $41.9 million in 2025.
  • Its Inventory Average stands at $41.9 million for Q3 2025, versus $40.2 million for Q2 2025 and $38.6 million for Q1 2025.